Section of Endocrinology and Metabolism, Marmara University Medical School, Istanbul, Turkey.
Metab Syndr Relat Disord. 2012 Feb;10(1):26-31. doi: 10.1089/met.2011.0052. Epub 2011 Sep 20.
Adipokines are markers of insulin resistance and play a role in the atherosclerotic process. The association of adipokines with the macrovascular complications of type 1 diabetes mellitus (DM) needs to be determined. The aim of this study was to measure serum adiponectin, leptin, and resistin levels in type 1 DM patients and investigate their relationship with carotid intima media thickness (CIMT), a clinical marker of atherosclerosis.
Seventy-five type 1 DM patients and 115 sex and age-matched healthy controls were included in the study. Serum adiponectin, leptin, and resistin levels were measured by the enzyme-linked immunosorbent assay (ELISA method). CIMT was assessed by Doppler ultrasonography.
Adiponectin levels in diabetics were higher (25.8±14.8 μg/mL vs. 5.5±7.3 μg/mL; P<0.0001) and leptin levels were lower than controls (9.4±6.2 ng/mL vs. 12.8±8.6 ng/mL; P=0.01). Resistin levels were also higher in the diabetic group compared to controls (2.1±1.4 ng/mL vs. 1.6±0.8 ng/mL; P=0.04). Adiponectin was correlated negatively with CIMT (r=-0.24, P=0.03), age (r=-0.30, P=0.02), BMI (r=-0.33, P=0.02), waist-to-hip ratio (WHR) (r=-0.38, P=0.01) and positively with creatinine (r=0.44, P=0.004). Leptin levels were correlated with total cholesterol (r=0.53, P=0.01) and high-density lipoprotein (HDL) (r=0.67, P=0.001). Resistin was correlated with CIMT (r=0.24, P=0.03) and systolic blood pressure (r=0.48, P=0.009). Multivariate analysis revealed resistin and creatinine to be independent predictors of CIMT among adiponectin, leptin, resistin, WHR, glycosylated hemoglobin (HbA1c), and creatinine.
Increased adiponectin correlates negatively and resistin positively with CIMT in type 1 diabetic patients, but adjusting for other known predictors reveals only resistin to be associated with subclinical atherosclerosis in this group of patients.
脂肪细胞因子是胰岛素抵抗的标志物,在动脉粥样硬化过程中发挥作用。需要确定脂肪细胞因子与 1 型糖尿病(DM)大血管并发症的关系。本研究的目的是测量 1 型 DM 患者的血清脂联素、瘦素和抵抗素水平,并探讨其与颈动脉内膜中层厚度(CIMT)的关系,CIMT 是动脉粥样硬化的临床标志物。
本研究纳入了 75 名 1 型 DM 患者和 115 名性别和年龄匹配的健康对照者。采用酶联免疫吸附试验(ELISA 法)测量血清脂联素、瘦素和抵抗素水平。通过多普勒超声评估 CIMT。
糖尿病患者的脂联素水平较高(25.8±14.8μg/ml 比 5.5±7.3μg/ml;P<0.0001),瘦素水平较低(9.4±6.2ng/ml 比 12.8±8.6ng/ml;P=0.01)。与对照组相比,糖尿病组的抵抗素水平也较高(2.1±1.4ng/ml 比 1.6±0.8ng/ml;P=0.04)。脂联素与 CIMT(r=-0.24,P=0.03)、年龄(r=-0.30,P=0.02)、BMI(r=-0.33,P=0.02)、腰臀比(WHR)(r=-0.38,P=0.01)呈负相关,与肌酐(r=0.44,P=0.004)呈正相关。瘦素水平与总胆固醇(r=0.53,P=0.01)和高密度脂蛋白(HDL)(r=0.67,P=0.001)呈正相关。抵抗素与 CIMT(r=0.24,P=0.03)和收缩压(r=0.48,P=0.009)呈正相关。多元分析显示,在脂联素、瘦素、抵抗素、WHR、糖化血红蛋白(HbA1c)和肌酐中,抵抗素和肌酐是 CIMT 的独立预测因子。
1 型糖尿病患者中,脂联素与 CIMT 呈负相关,抵抗素与 CIMT 呈正相关,但在调整其他已知预测因子后,只有抵抗素与该组患者的亚临床动脉粥样硬化相关。